Artiva Biotherapeutics, Inc.
ARTV
56 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 6, 2026 | Oct 7 8:02 PM | Fred AslanDirector, Chief Executive Officer | Sale | 23,463 | $7.20 | $168.9K | 1,519,606(D) | View → |
| Oct 6, 2026 | Oct 6 8:21 PM | FRED ASLAN | Proposed Sale | 34,465 | $7.13 | $245.7K | — | View → |
| Oct 5, 2026 | Oct 6 8:02 PM | Christopher HoranChief Tech Operations Officer | Sale | 10,340 | $6.84 | $70.7K | 312,744(D) | View → |
| Oct 5, 2026 | Oct 6 8:02 PM | Jennifer BushCOO, CLO, Compliance Officer | Sale | 8,370 | $6.84 | $57.2K | 366,159(D) | View → |
| Oct 5, 2026 | Oct 6 8:02 PM | Subhashis BanerjeeChief Medical Officer | Sale | 1,099 | $6.84 | $7.5K | 169,848(D) | View → |
| Oct 5, 2026 | Oct 6 8:01 PM | Fred AslanDirector, Chief Executive Officer | Sale | 61,696 | $6.84 | $421.8K | 1,543,069(D) | View → |
| Sep 8, 2026 | Sep 9 8:02 PM | Fred AslanDirector, Chief Executive Officer | Sale | 23,429 | $10.92 | $255.7K | 1,449,765(D) | View → |
| Sep 8, 2026 | Sep 8 8:31 PM | FRED ASLAN | Proposed Sale | 23,429 | $11.19 | $262.2K | — | View → |
| Sep 3, 2026 | Sep 4 8:04 PM | Christopher HoranChief Tech Operations Officer | Sale | 10,366 | $11.16 | $115.6K | 283,084(D) | View → |
| Sep 3, 2026 | Sep 4 8:03 PM | Jennifer BushCOO, CLO, Compliance Officer | Sale | 8,391 | $11.16 | $93.6K | 329,529(D) | View → |
| Sep 3, 2026 | Sep 4 8:03 PM | Subhashis BanerjeeChief Medical Officer | Sale | 1,100 | $11.16 | $12.3K | 140,947(D) | View → |
| Sep 3, 2026 | Sep 4 8:02 PM | Fred AslanDirector, Chief Executive Officer | Sale | 61,888 | $11.16 | $690.4K | 1,473,194(D) | View → |
| Aug 27, 2026 | Aug 31 11:06 PM | Subhashis BanerjeeChief Medical Officer | Sale | 8,222 | $12.01 | $98.7K | 142,047(D) | View → |
| Aug 27, 2026 | Aug 27 8:19 PM | SUBHASHIS BANERJEE | Proposed Sale | 7,818 | $11.77 | $92.0K | — | View → |
| Aug 18, 2026 | Aug 20 1:00 AM | Subhashis BanerjeeChief Medical Officer | Sale | 429 | $12.00 | $5.1K | 144,963(D) | View → |
| Aug 18, 2026 | Aug 18 8:30 PM | SUBHASHIS BANERJEE | Proposed Sale | 833 | $11.74 | $9.8K | — | View → |
| Jul 31, 2026 | Jul 31 9:13 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 24,944 | $9.93 | $247.7K | 17,329,570(I) | View → |
| Jul 29, 2026 | Jul 31 9:13 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 20,824 | $9.99 | $208.0K | 17,304,626(I) | View → |
| Jul 24, 2026 | Jul 28 9:24 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 41,319 | $9.99 | $412.8K | 17,283,802(I) | View → |
| Jul 23, 2026 | Jul 24 1:22 AM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 59,880 | $9.96 | $596.4K | 17,242,483(I) | View → |
Page 1 of 3
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Aug 27, 2026 | Aug 31 11:06 PM | Subhashis BanerjeeChief Medical Officer | Option Exercise | 5,306 | $1.92 | 74,265(D) | View → |
| Aug 18, 2026 | Aug 20 1:00 AM | Subhashis BanerjeeChief Medical Officer | Option Exercise | 429 | $1.92 | 79,571(D) | View → |
| May 18, 2026 | May 19 12:11 PM | Gines Diego MirallesPresident & Head of R&D | Grant/Award | 232,500 | $9.22 | 232,500(D) | View → |
| May 11, 2026 | May 13 9:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 2,170,138 | $0.0001 | 2,170,138(I) | View → |
| Feb 18, 2026 | Feb 20 2:50 AM | Elaine K. SorgDirector | Grant/Award | 27,500 | $4.15 | 27,500(D) | View → |
← Previous
Page 2 of 2